Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03010051 15d PGD2 cPLA2i 1.0 BCD110605C30 4.51 pmol/ml medium
LMFA03010051 15d PGD2 cPLA2i 1.0 BCD110605C29 3.24 pmol/ml medium
LMFA03010051 15d PGD2 cPLA2i 1.0 BCD110605C28 5 pmol/ml medium
LMFA03010051 15d PGD2 cPLA2i 20.0 BCD110605C64 6.06 pmol/ml medium
LMFA03010051 15d PGD2 cPLA2i 20.0 BCD110605C66 4.66 pmol/ml medium
LMFA03010051 15d PGD2 cPLA2i 20.0 BCD110605C65 4.61 pmol/ml medium
LMFA03010051 15d PGD2 PLDi 1.0 BCD110605C16 3.15 pmol/ml medium
LMFA03010051 15d PGD2 PLDi 1.0 BCD110605C18 3.99 pmol/ml medium
LMFA03010051 15d PGD2 PLDi 1.0 BCD110605C17 3.46 pmol/ml medium
LMFA03010051 15d PGD2 PLDi 20.0 BCD110605C52 4.84 pmol/ml medium
LMFA03010051 15d PGD2 PLDi 20.0 BCD110605C54 4.8 pmol/ml medium
LMFA03010051 15d PGD2 PLDi 20.0 BCD110605C53 6.3 pmol/ml medium
LMFA03010051 15d PGD2 KDO+cPLA2i 1.0 BCD110605C32 4.5 pmol/ml medium
LMFA03010051 15d PGD2 KDO+cPLA2i 1.0 BCD110605C33 2.78 pmol/ml medium
LMFA03010051 15d PGD2 KDO+cPLA2i 1.0 BCD110605C31 1.97 pmol/ml medium
LMFA03010051 15d PGD2 KDO+cPLA2i 20.0 BCD110605C69 6.53 pmol/ml medium
LMFA03010051 15d PGD2 KDO+cPLA2i 20.0 BCD110605C67 4.97 pmol/ml medium
LMFA03010051 15d PGD2 KDO+cPLA2i 20.0 BCD110605C68 6.44 pmol/ml medium
LMFA03010051 15d PGD2 KDO+PLDi 1.0 BCD110605C21 3.81 pmol/ml medium
LMFA03010051 15d PGD2 KDO+PLDi 1.0 BCD110605C20 4.34 pmol/ml medium
LMFA03010051 15d PGD2 KDO+PLDi 1.0 BCD110605C19 2.96 pmol/ml medium
LMFA03010051 15d PGD2 KDO+PLDi 20.0 BCD110605C57 5.89 pmol/ml medium
LMFA03010051 15d PGD2 KDO+PLDi 20.0 BCD110605C56 6.53 pmol/ml medium
LMFA03010051 15d PGD2 KDO+PLDi 20.0 BCD110605C55 6.92 pmol/ml medium
LMFA03010051 15d PGD2 KDO+ATP+cPLA2i 1.0 BCD110605C37 2.83 pmol/ml medium
LMFA03010051 15d PGD2 KDO+ATP+cPLA2i 1.0 BCD110605C39 2.28 pmol/ml medium
LMFA03010051 15d PGD2 KDO+ATP+cPLA2i 1.0 BCD110605C38 4.52 pmol/ml medium
LMFA03010051 15d PGD2 KDO+ATP+cPLA2i 20.0 BCD110605C74 8.11 pmol/ml medium
LMFA03010051 15d PGD2 KDO+ATP+cPLA2i 20.0 BCD110605C73 5.43 pmol/ml medium
LMFA03010051 15d PGD2 KDO+ATP+cPLA2i 20.0 BCD110605C75 8.65 pmol/ml medium
LMFA03010051 15d PGD2 KDO+ATP+PLDi 1.0 BCD110605C27 1.99 pmol/ml medium
LMFA03010051 15d PGD2 KDO+ATP+PLDi 1.0 BCD110605C25 2.49 pmol/ml medium
LMFA03010051 15d PGD2 KDO+ATP+PLDi 1.0 BCD110605C26 2.81 pmol/ml medium
LMFA03010051 15d PGD2 KDO+ATP+PLDi 20.0 BCD110605C62 10 pmol/ml medium
LMFA03010051 15d PGD2 KDO+ATP+PLDi 20.0 BCD110605C63 11.6 pmol/ml medium
LMFA03010051 15d PGD2 KDO+ATP+PLDi 20.0 BCD110605C61 10.2 pmol/ml medium
LMFA03010051 15d PGD2 KDO + ATP 1.0 BCD110605C14 1.09 pmol/ml medium
LMFA03010051 15d PGD2 KDO + ATP 1.0 BCD110605C15 2.57 pmol/ml medium
LMFA03010051 15d PGD2 KDO + ATP 1.0 BCD110605C13 1.9 pmol/ml medium
LMFA03010051 15d PGD2 KDO + ATP 20.0 BCD110605C49 12 pmol/ml medium
LMFA03010051 15d PGD2 KDO + ATP 20.0 BCD110605C51 11.1 pmol/ml medium
LMFA03010051 15d PGD2 KDO + ATP 20.0 BCD110605C50 13.5 pmol/ml medium
LMFA03010051 15d PGD2 KDO 1.0 BCD110605C09 1.85 pmol/ml medium
LMFA03010051 15d PGD2 KDO 1.0 BCD110605C08 3.96 pmol/ml medium
LMFA03010051 15d PGD2 KDO 1.0 BCD110605C07 2.65 pmol/ml medium
LMFA03010051 15d PGD2 KDO 20.0 BCD110605C45 2.68 pmol/ml medium
LMFA03010051 15d PGD2 KDO 20.0 BCD110605C44 6.66 pmol/ml medium
LMFA03010051 15d PGD2 KDO 20.0 BCD110605C43 5.42 pmol/ml medium
LMFA03010051 15d PGD2 C 0.0 BCD110605C02 4.45 pmol/ml medium
LMFA03010051 15d PGD2 C 0.0 BCD110605C01 1.86 pmol/ml medium